Inventor
HAGNER PATRICK
US3 patents
Patents
3 patentsUS10996215B2May 4, 2021
Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
CELGENE CORP5 citations67
US10689708B2Jun 23, 2020
Methods for treating diffuse large B-cell lymphoma and the use of biomarkers as a predictor of responsiveness to drugs
CELGENE CORP3 citations67
US10159675B2Dec 25, 2018
Cycling therapy using 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione
CELGENE CORP0 citations48